Clinical and Experimental Nephrology

Article	Citations
Hypokalemia in Patients with COVID-19	79
The emerging role of magnesium in CKD	35
Estimating the prevalence of definitive chronic kidney disease in the Japanese general population	30
Incidence and risk factors of acute kidney injury, and its effect on mortality among Japanese patients receiving immune check point inhibitors: a single-center observational study	27
Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase II, randomized, double-blind, placebo-controlled clinical study	24
Emerging cross-talks between chronic kidney disease–mineral and bone disorder (CKD–MBD) and malnutrition–inflammation complex syndrome (MICS) in patients receiving dialysis	24
A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020	24
Kidney biopsy guidebook 2020 in Japan	24
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19	24
Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study	23
Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version	23
Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia	23
Pathology and pathogenic pathways in fabry nephropathy	23
Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan	19
Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats	19
Intra-body dynamics of d-serine reflects the origin of kidney diseases	18
Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy	18
The roles of histone deacetylases in kidney development and disease	18
Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease	18
COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine	17
Causes of death in patients undergoing maintenance hemodialysis in Japan: 10-year outcomes of the Q-Cohort Study	17
Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study	16
Clinical profile and outcomes of COVID-19 patients with acute kidney injury: a tertiary centre experience from South India	15
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020	15
Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease	14

iPSC technology-based regenerative medicine for kidney diseases	14
Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular or all-cause mortality in chronic kidney disease: a meta-analysis	14
Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients	13
Activators of SIRT1 in the kidney and protective effects of SIRT1 during acute kidney injury (AKI) (effect of SIRT1 activators on acute kidney injury)	13
Reno-protective effects of Phosphodiesterase 5 inhibitors	13
Impact of visceral fat area in patients with chronic kidney disease	13
Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome	12
Activation of AQP2 water channels by protein kinase A: therapeutic strategies for congenital nephrogenic diabetes insipidus	12
Development and validation of a predictive model for acute kidney injury in patients with moderately severe and severe acute pancreatitis	12
Association between serum uric acid and new onset and progression of chronic kidney disease in a Japanese general population: Iki epidemiological study of atherosclerosis and chronic kidney disease	12
A digest from evidence-based clinical practice guideline for IgA nephropathy 2020	12
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients	12
Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort study	11
Nutritional status and risk of contrast-associated acute kidney injury in elderly patients undergoing percutaneous coronary intervention	11
The association between frailty and chronic kidney disease; cross-sectional analysis of the Nambu Cohort Study	11
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia	11
The association between renal elasticity evaluated by Real-time tissue elastography and renal fibrosis	11
Low-GDP, pH-neutral solutions preserve peritoneal endothelial glycocalyx during long-term peritoneal dialysis	10
Fact-finding survey on health literacy among Japanese predialysis chronic kidney disease patients: a multi-institutional cross-sectional study	10
Analysis of risk factors for donation after circulatory death kidney transplantation in Japan	10
Evaluation of a newly proposed renal risk score for Japanese patients with ANCA-associated glomerulonephritis	10
Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus	9
Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study	9
Calcium channel blocker in patients with chronic kidney disease	9
MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1	9
Total iron binding capacity is a predictor for muscle loss in maintenance hemodialysis patients	9
Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study	9
Creatinine generation rate can detect sarcopenia in patients with hemodialysis	9
Safety and efficacy of Tolvaptan in real-world patients with autosomal dominant polycystic kidney disease- interim results of SLOW-PKD surveillance	9
Renal prognoses by different target hemoglobin levels achieved by epoetin beta pegol dosing to chronic kidney disease patients with hyporesponsive anemia to erythropoiesis-stimulating agent: a multice	9
Zinc deficiency: its prevalence and relationship to renal function in Japan	9
Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19	9
Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidney	9
Clinical and morphologic spectrum of renal involvement in idiopathic hypereosinophilic syndrome	8
Incidence of end-stage renal disease and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry	8
Clinical characteristics of COVID-19 infection in a dialysis center during a nosocomial outbreak	8
A cross-sectional study in patients with IgA nephropathy of correlations between clinical data and pathological findings at the time of renal biopsy: a Japanese prospective cohort study	8
Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD)	8
Effect of lanthanum carbonate and calcium carbonate on the progression of coronary artery calcification among hemodialysis patients with vascular calcification risk: a randomized controlled trial	8
Inpatient educational program delays the need for dialysis in patients with chronic kidney disease stage G5	8
Circ_0000064 knockdown attenuates high glucose-induced proliferation, inflammation and extracellular matrix deposition of mesangial cells through miR-424-5p-mediated WNT2B inhibition in cell models of	8
Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis	8
X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay	8
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan	7
Association of the nutritional risk index for Japanese hemodialysis patients with long-term mortality: The Q-Cohort Study	7
New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan	7
The association between cognitive impairment/dementia and albuminuria: a systematic review and meta-analysis	7
Effectiveness and current status of multidisciplinary care for patients with chronic kidney disease in Japan: a nationwide multicenter cohort study	7
Preoperative CT volumetry of estimated residual kidney for prediction of postoperative chronic kidney disease in patients with renal cell carcinoma	7
Comparative study of a novel selective urate reabsorption inhibitor “dotinurad” among patient groups with different stages of renal dysfunction	7

Impact of water consumption on renal function in the general population: a cross-sectional analysis of KNHANES data (2008–2017)	7
Pregnancy outcomes in patients with systemic lupus erythematosus with or without a history of lupus nephritis	7
Cardio-ankle vascular index with renal progression and mortality in high atherosclerosis risk: a prospective cohort study in CORE-Thailand	7
Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan	7
Dialysis-related carpal tunnel syndrome in the past 40 years	7
Seasonal variation of serum 25-hydroxyvitamin D level in hemodialysis patients in the northernmost island of Japan	7
Clinical and experimental approaches for imaging of acute kidney injury	7
Hemodialysis patients with coronavirus disease 2019: reduced antibody response	7
PPAR-δ activation reduces cisplatin-induced apoptosis via inhibiting p53/Bax/caspase-3 pathway without modulating autophagy in murine renal proximal tubular cells	6
Efficacy and safety of mycophenolate mofetil in the treatment for IgA nephropathy: a meta-analysis of randomized controlled trials	6
Renal morphology and function from childhood to adulthood in Turner syndrome	6
All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome	6
Expression and prognostic value of CXCL12/CXCR4/CXCR7 axis in clear cell renal cell carcinoma	6
Long-term outcomes of IgA nephropathy patients with less than 25% crescents and mild proteinuria	6
eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database	6
Improving hepatitis B vaccination rates for advanced chronic kidney disease patients: a quality improvement initiative	6
Screening of renal anomalies in first-degree relatives of children diagnosed with non-syndromic congenital anomalies of kidney and urinary tract	6
Cost-effectiveness of mass screening for dipstick hematuria in Japan	6
Tubulointerstitial nephritis: a biopsy case series of 139 Japanese patients	6
Impact of polypharmacy on all-cause mortality and hospitalization in incident hemodialysis patients: a cohort study	6
KCNQ1OT1 inhibition alleviates high glucose-induced podocyte injury by adsorbing miR-23b-3p and regulating Sema3A	6
Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study	6
Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial	6
A possible case of carbamazepine-induced renal phospholipidosis mimicking Fabry disease	6
The distribution of eGFR by age in a community-based healthy population: the Japan specific health checkups study (J-SHC study)	6
Roles of PTH and FGF23 in kidney failure: a focus on nonclassical effects	6
Efficacy of continuous erythropoietin receptor activator for end-stage renal disease patients with renal anemia before and after peritoneal dialysis initiation	6
Association of magnesium abnormalities at intensive care unit admission with kidney outcomes and mortality: a prospective cohort study	6
Altered arginine vasopressin-cyclic AMP-aquaporin 2 pathway in patients with chronic kidney disease	6
Chronic kidney disease and clinical outcomes in patients with COVID-19 in Japan	6
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease	6
Performance of ChatGPT and Bard in self-assessment questions for nephrology board renewal	6
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in maintenance dialysis: a meta-analysis	6
Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease	5
Profiling of kidney involvement in systemic lupus erythematosus by deep learning using the National Database of Designated Incurable Diseases of Japan	5
Predictive factors and management of urinary tract infections after kidney transplantation: a retrospective cohort study	5
Acute kidney injury in cancer patients	5
Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients	5
Immune checkpoint inhibitor-associated acute kidney injury in patients with cancer: a systematic review and meta-analysis of risk factors	5
Effects of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy	5
VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience	5
Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilities	5
Hematological parameters of anemia and prognosis of non-dialysis-dependent chronic kidney disease: the Fukushima CKD cohort study	5
Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury	5
Estimating the causal effect of transient anemia status on renal and cardiovascular outcomes in community-dwelling patients in Japan at the beginning of impaired renal function using marginal structur	5
A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan	5
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis	5
Relationships of hyperchloremia with hypertension and proteinuria in patients with chronic kidney disease	5
Brain-derived neurotrophic factor (BDNF): a multifaceted marker in chronic kidney disease	5
Tracing all patients who received insured dialysis treatment in Japan and the present situation of their number of deaths	5
Factors predicting the recovery from acute kidney injury in children with primary nephrotic syndrome	5
Constipation and diabetic kidney disease: The Fukuoka Diabetes Registry	5
Ultrasonographic reference values and a simple yet practical formula for estimating average kidney length in Japanese children	5
Prognostic impact of renal sinus fat accumulation in patients with chronic kidney disease	5
Sex differences in clinical outcomes in Japanese incident dialysis patients: a prospective observational multicenter study	5
Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat	5
Serum alkaline phosphatase and infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-cohort study	4
Association between COVID-19 vaccination and relapse of glomerulonephritis	4
Incidence and risk factors of overcorrection in patients presenting with severe hyponatremia to the emergency department	4
Peritoneal dialysis (PD) technique training: what features influence learning time?	4
Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosis	4
Prevalence of latent tuberculosis infection and its risk factors in Japanese hemodialysis patients	4
Prevalence and determinants of chronic kidney disease in urban adults’ populations of northern Cameroon	4
Association of polypharmacy with incidence of CKD: a retrospective cohort study	4
Decreased GM3 correlates with proteinuria in minimal change nephrotic syndrome and focal segmental glomerulosclerosis	4
Peritoneal dialysis training performed remotely: results and comparison with Home Training	4
Neferine mitigates cisplatin-induced acute kidney injury in mice by regulating autophagy and apoptosis	4
Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience	4
Risk factors for the in-hospital mortality of CRRT-therapy patients with cardiac surgery-associated AKI: a single-center clinical study in China	4
N-terminal pro brain natriuretic peptide predicts both all-cause and cardiovascular disease mortality in Japanese hemodialysis patients	4
Cyclosporine A C1.5 monitoring reflects the area under the curve in children with nephrotic syndrome: a single-center experience	4
The immunohistochemical expression of von Willebrand factor, T-cadherin, and Caveolin-1 is increased in kidney allograft biopsies with antibody-mediated injury	4
The effect of renal replacement therapy on health-related quality of life in end-stage renal disease: a meta-analysis	4
Weight loss reduces the incidence of dipstick proteinuria: a cohort study from the Japanese general population	4
The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre study	4
Neuroimmune system-mediated renal protection mechanisms	4
Hepatocyte growth factor ameliorates methylglyoxal-induced peritoneal inflammation and fibrosis in mouse model	4
Lateral spine dual-energy X-ray absorptiometry and the risk of fragility fractures in long-term kidney graft recipients	4
Efficacy and limitations of additional steroid pulse therapy in IgA nephropathy patients whose hematuria did not remit on tonsillectomy and protocol steroid pulse therapy	4
Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study	4

Prevalence, treatment status, and predictors of anemia and erythropoietin hyporesponsiveness in Japanese patients with non-dialysis-dependent chronic kidney disease: a cross-sectional study	4
Post-kidney transplant soluble Klotho levels are determined by pretransplant soluble Klotho levels in both living donors and recipients	4
Association of the nutritional risk index for Japanese hemodialysis with mortality and dietary nutritional intake in patients undergoing hemodialysis during long-term hospitalization	4
Correlation between IgAC3 ratio and oxford score in IgA nephropathy	4
Prognostic factors of IgA nephropathy presenting with mild proteinuria at the time of diagnosis (a multicenter cohort study)	4
Predictive value of suPAR in AKI: a systematic review and meta-analysis	4
Clinical features of autosomal recessive polycystic kidney disease in the Japanese population and analysis of splicing in PKHD1 gene for determination of phenotypes	4
Epidemiology and temporal changes in the prognosis of rapidly progressive glomerulonephritis in Japan: a nationwide 1989–2015 survey	4
Demographic, clinical and laboratory characteristics of rapidly progressive glomerulonephritis in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group	4
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects	4
Pathophysiology of encapsulating peritoneal sclerosis: lessons from findings of the past three decades in Japan	4
Long-term social outcome after pediatric kidney transplantation: a single-center experience	4
Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study	4
Clinical and histopathological features of acute kidney injury in adult-onset minimal change nephrotic syndrome	4